このエピソードについて
Mark and Howard are joined by Sarah Holland, Chief Business Officer at Swiss biotech CDR Life and President of the Swiss Healthcare Licensing Group, to explore what intelligence looks like in the private sector.
Sarah explains how biotech companies use competitive intelligence, scientific data, market insight, expert networks, conferences, regulatory signals, and even industry gossip to make high-stakes decisions about drug development and partnerships.
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
In this episode, Mark and Howard are joined by David Allen, a former Metropolitan Police officer who joined the job in 1966 and later became a collator at Bow Street. David shares what policing the West End was really like, how the Collator's Office worked, and why apparently trivial scraps of info…
Mark and Howard are joined by Ian Jackson for a wide-ranging conversation about comics, science fiction, nostalgia, imagination, and critical thinking. Ian shares his journey from archaeology, theatre, travel, and art handling to running a one-man comic shop built around nostalgia, community, and g…
This week, we are doubly blessed to welcome back a very special guest: Konstantin from the Inside Russia YouTube channel. Moving past regular news cycles, we sit down for a deep, philosophical, and deeply personal conversation about the global information shift and the decaying trust in our media i…
Dean Baratta joins The Collators to discuss a career that has taken him from Cold War military intelligence to law enforcement, homeland security, and the private sector. Dean also reflects on the future of the field, the danger of losing apprenticeship style learning, and why the next generation o…
免責: このページに埋め込まれているポッドキャストとアートワークは Mark Lockwood, Howard Atkin からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
